A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis: The epithelial keratitis trial

Archives of Ophthalmology

Volumn 115, Issue 6, 1997, Pages 703-712

  Barron, Bruce A ^b   Beck, Roy W ^a   Asbell, Penny A ^b   Cohen, Elisabeth J ^b   Dawson, Chandler R ^b   Hyndiuk, Robert A ^b   Jones, Dan B ^b   Kaufman, Herbert E ^b   Kurinij, Natalie ^b   Moke, Pamela S ^b   Stulting, R Doyle ^b   Sugar, Joel ^b   Wilhelmus, Kirk R ^b  

^a JAEB CENTER FOR HEALTH RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TRIFLURIDINE;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HERPES SIMPLEX VIRUS; HUMAN; IRITIS; KERATITIS; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING;

EID: 8544223523     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1997.01100150705001     Document Type: Article

References (12)

1. National Institutes of Health. Workshop on the treatment and prevention of herpes simplex virus infections. J Infect Dis. 1973;127:117-119.
2. Liesegang TJ, Melton LJ, Daly PJ, Ilstrup DM. Epidemiology of ocular herpes simplex: incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol. 1989;107:1155-1159.
3. Dawson CR, Togni B. Herpes simplex eye infections: clinical manifestations, pathogenesis and management. Surv Ophthalmol. 1976;21:121-135.
4. Repose JS. Herpes simplex keratitis: role of viral infection versus immune response. Surv Ophthalmol. 1991;35:345-352.
5. Liesegang TJ. Epidemiology of ocular herpes simplex: natural history in Rochester, Minn, 1950 through 1982. Arch Ophthalmol. 1989;107:1160-1165.
6. Norn MS. Dendritic (herpetic) keratitis, I: incidence, seasonal variations, recurrence rate, visual impairment, therapy. Acta Ophthalmol. 1970;48:91-107.
7. McGill J, Williams H, McKinnon J, et al. Reassessment of idoxuridine therapy of herpetic keratitis. Trans Ophthalmol Soc U K. 1974;94:542-552.
8. McGill J, Holt-Wilson AD, McKinnon JR, et al. Some aspects of the clinical use of trifluorothymidine in the treatment of herpetic ulceration of the cornea. Trans Ophthalmol Soc U K. 1974;94:342-352.
9. Wilhelmus KR, Coster DJ, Donovan HC, et al. Prognostic indicators of herpetic keratitis: analysis of a five-year observation period after corneal ulceration. Arch Ophthalmol. 1981;99:1578-1582.
10. Herpetic Eye Disease Study Group. Manual of Operations, version date August 1, 1994. Available from the National Technical Information Service, Springfield, Va (accession No. PB97-112999).
11. Mantel N, Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep. 1966;50:163-170.
12. Hung SO, Patterson A, Rees PJ. Pharmacokinetics of oral acyclovir (Zovirax) in the eye. Br J Ophthalmol. 1984;68:192-195.